Skip to main content
. 2008 Jun;152(3):482–487. doi: 10.1111/j.1365-2249.2008.03646.x

Table 3.

Relative quantification of Toll-like receptors (TLRs) mRNA expression [control versus systemic lupus erythematosus (SLE) patients].

Control SLE P-value*
TLR-2 0·082 ± 0·045 0·119 ± 0·058 0·019
TLR-3 1·801 ± 2·137 2·609 ± 2·069 0·089
TLR-4 3·035 ± 1·505 4·407 ± 2·239 0·051
TLR-5 0·243 ± 0·184 0·269 ± 0·132 0·279
TLR-7 1·365 ± 1·171 1·872 ± 0·756 0·011
TLR-8 3·658 ± 1·854 3·473 ± 1·985 0·741
TLR-9 1·477 ± 1·883 2·791 ± 1·914 0·007
IFN-α 0·037 ± 0·045 0·069 ± 0·059 0·033
LY6E 0·094 ± 0·044 0·343 ± 0·163 0·0000067
*

P-value was estimated by Mann–Whitney U-test. LY6E, lymphocyte antigen 6 complex, locus E; IFN, interferon.